Long-term survival following medical management of Aspergillus endocarditis with dissemination as a consequence of steroid therapy in severe COVID-19 pneumonia.

Autor:	Kulirankal KG; Division of Infectious Diseases, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India., Mary A; Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India., Moni M; Division of Infectious Diseases, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India., Pillai GS; Department of Ophthalmology, Amrita Institute of Medical Sciences, Kochi, India., Sathyapalan DT; Division of Infectious Diseases, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India.
Jazyk:	angličtina
Zdroj:	Medical mycology case reports [Med Mycol Case Rep] 2024 Mar 01; Vol. 43, pp. 100638. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).
DOI:	10.1016/j.mmcr.2024.100638
Abstrakt:	A male in his 40's with no known comorbidities developed severe COVID-19 pneumonia and received a four-week course of methylprednisolone. The patient subsequently developed disseminated Aspergillus endocarditis, manifesting as multiple organ involvement including the heart, eyes, and brain. Despite the poor prognosis generally associated with fungal endocarditis, the patient survived following aggressive medical management with a combination of liposomal amphotericin b and voriconazole therapy and is now doing well for over two years and is off antifungal therapy for a year. Competing Interests: There are none. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu